Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Protiviti's Jim DeLoach Recognized on NACD Directorship 100 List for Fifth Consecutive Year

Protiviti
Posted on: 22 Nov 16

MENLO PARK, Calif., Nov. 22, 2016 /PRNewswire/ -- For the fifth consecutive year, the National Association of Corporate Directors (NACD) has named Jim DeLoach, a managing director at global consulting firm Protiviti, to its 2016 NACD Directorship 100 list. DeLoach is being recognized in the Governance Professionals and Institutions category. The NACD Directorship 100 list, published annually, identifies the most influential members of the boardroom community including directors, corporate governance experts, journalists, regulators and advisors.

"Jim has evolved into one of the most well-respected and trusted leaders in the corporate governance arena. His deep insights into the integration of business strategy and risk management have positioned him as a top industry expert and thought leader," said Joseph Tarantino, president and CEO, Protiviti. "We're extremely proud of Jim for receiving this honor yet again from the NACD, which further solidifies his role as a leader in the governance and risk management space and emphasizes his continued contributions to the industry."

With more than 40 years of experience, DeLoach focuses on helping organizations successfully respond to government mandates, shareholder demands and a changing business environment in a cost-effective and sustainable manner. He assists companies in integrating risk and risk management with strategy setting and performance management as a member of Protiviti's solutions leadership team. A prolific writer, DeLoach also leads Protiviti's thought leadership strategy and has published more than 300 articles over the past 15 years, discussing topics ranging from governance, managing business risk and effective internal controls. DeLoach is the author of Protiviti's Board Perspectives: Risk Oversight series and The Bulletin, as well as the primary author of the firm's blog, The Protiviti View. In 2000, the Financial Times published his book, Enterprise-wide Risk Management: Strategies, becoming the first book written on the subject of enterprise risk management. Additionally, DeLoach contributes monthly articles to CorporateComplianceInsights.com and the NACD publication Directorship. He is based in Protiviti's Houston office.

"NACD is honored to recognize the achievements and commitment to boardroom excellence exemplified by these exceptional individuals. Effective corporate directors and governance leaders are nothing short of essential to the success of the enterprise – from creating and sustaining long-term value to serving as a guiding light in times of disruption," said Ken Daly, CEO of NACD.

NACD Directorship 100 honorees are selected by a group that includes the previous year's honorees, an advisory panel of judges and NACD Directorship readers and staff. The 2016 honorees will be celebrated at the 10th Annual NACD Directorship 100 Gala on November 30, 2016 in New York City. The full list of the 2016 NACD Directorship 100 honorees can be found at https://www.nacdonline.org/directorship100/2016honorees.cfm.

About Protiviti
Protiviti (www.protiviti.com) is a global consulting firm that delivers deep expertise, objective insights, a tailored approach and unparalleled collaboration to help leaders confidently face the future. Through its network of more than 70 offices in over 20 countries, Protiviti and its independently owned Member Firms provide clients with consulting solutions in finance, technology, operations, data analytics, governance, risk and internal audit.

Protiviti has served more than 60 percent of Fortune 1000® and 35 percent of Fortune Global 500® companies. The firm also works with smaller, growing companies, including those looking to go public, as well as with government agencies. Protiviti is a wholly owned subsidiary of Robert Half (NYSE: RHI). Founded in 1948, Robert Half is a member of the S&P 500 index.

Protiviti is not licensed or registered as a public accounting firm and does not issue opinions on financial statements or offer attestation services.

Editor's note: Photos available upon request.

For more information:
www.protiviti.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 22/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.